dilazep has been researched along with Serum Sickness in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Serum Sickness: Immune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inage, H | 1 |
| Koyama, A | 1 |
| Narita, M | 1 |
| Tojo, S | 1 |
1 other study available for dilazep and Serum Sickness
| Article | Year |
|---|---|
Effects of dilazep dihydrochloride (Dilazep) and its dose-dependent influence on rabbit acute serum sickness nephritis.
Topics: Acute Disease; Animals; Azepines; Dilazep; Male; Nephritis; Rabbits; Serum Sickness | 1985 |